Latest Breaking News On - Oday abvx fr0012333284 - Page 1 : comparemela.com

Abivax SA , a clinical-stage biotechnology company developing novel therapies that modulate the immune system to treat chronic inflammatory diseases, viral infections, and cancer, today reports. | March 10, 2022

France generalUnited kingdomHartmutj ehrlichWilliam robinsonEnregistrement universelPaul emeryDivision of immunologyLeeds teaching hospitalsLeeds musculoskeletal biomedical research centreAmerican college of rheumatologyLeeds institute of rheumaticStanford universityEuronext parisVersus arthritis professorLeeds teaching hospitals trustLeeds institute